Try our beta test site

Alisertib for Acute Myeloid Leukemia

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Amir Fathi, Massachusetts General Hospital
ClinicalTrials.gov Identifier:
NCT01779843
First received: January 25, 2013
Last updated: February 15, 2017
Last verified: February 2017